SINOVAC BIOTECH LTD Cash And Cash Equivalents At Carrying Value

Quick Answer

SINOVAC BIOTECH LTD reported Cash And Cash Equivalents At Carrying Value of $1.27 billion for the year ending 2023.

  • SINOVAC BIOTECH LTD showed a decrease of -70.3% in Cash And Cash Equivalents At Carrying Value from 2022 to 2023.
  • This data is from SINOVAC BIOTECH LTD's annual report (Form 10-K), filed with the SEC on April 29, 2024.
  • XBRL data for this metric is available from 2008 to 2023 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 16 years of available data (2008 to 2023), SINOVAC BIOTECH LTD's Cash And Cash Equivalents At Carrying Value has grown by 3,761.3%.
  • Historical annual values: Fiscal year 2023: $1.27 billion | Fiscal year 2022: $4.28 billion | Fiscal year 2021: $11.61 billion | Fiscal year 2020: $1.04 billion | Fiscal year 2019: $152.72 million | Fiscal year 2018: $158.17 million | Fiscal year 2017: $114.42 million | Fiscal year 2016: $62.43 million | Fiscal year 2015: $63.83 million | Fiscal year 2014: $89.79 million | Fiscal year 2013: $106.52 million | Fiscal year 2012: $91.22 million | Fiscal year 2011: $104.29 million | Fiscal year 2010: $101.59 million | Fiscal year 2009: $74.95 million | Fiscal year 2008: $32.89 million.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: